drugset / Trial / NCT02564926
Foxiga Korea Local Phase 4 Study
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the effect of dapagliflozin on body composition in Korean T2DM subjects.12-month, randomised, open-label, parallel-group, multi-centre phase IV study.
Timeline
- Start
- 2016-01-05
- Primary completion
- 2018-01-15
- Completion
- 2018-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | — |
| Comparator | Glimepiride | Small molecule | 1 mg | — |
| Comparator | Glimepiride | Small molecule | 2 mg | — |
| Background | Metformin | Small molecule | 1000 mg | — |